scholarly journals Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The Netherlands.

1994 ◽  
Vol 32 (2) ◽  
pp. 306-310 ◽  
Author(s):  
G E Kleter ◽  
L J van Doorn ◽  
J T Brouwer ◽  
S W Schalm ◽  
R A Heijtink ◽  
...  
2007 ◽  
Vol 45 (4) ◽  
pp. 1102-1112 ◽  
Author(s):  
D. G. Murphy ◽  
B. Willems ◽  
M. Deschenes ◽  
N. Hilzenrat ◽  
R. Mousseau ◽  
...  

Transfusion ◽  
2006 ◽  
Vol 46 (10) ◽  
pp. 1719-1728 ◽  
Author(s):  
Thijs J.W. Van De Laar ◽  
Marco H.G.M. Koppelman ◽  
Akke K. Van Der Bij ◽  
Hans L. Zaaijer ◽  
H. Theo M. Cuijpers ◽  
...  

2014 ◽  
Vol 95 (1) ◽  
pp. 66-70 ◽  
Author(s):  
Victoria C. Edwards ◽  
C. Patrick McClure ◽  
Richard J. P. Brown ◽  
Emma Thompson ◽  
William L. Irving ◽  
...  

Sequence analysis is used to define the molecular epidemiology and evolution of the hepatitis C virus. Whilst most studies have shown that individual patients harbour viruses that are derived from a limited number of highly related strains, some recent reports have shown that some patients can be co-infected with very distinct variants whose frequency can fluctuate greatly. Whilst co-infection with highly divergent strains is possible, an alternative explanation is that such data represent contamination or sample mix-up. In this study, we have shown that DNA fingerprinting techniques can accurately assess sample provenance and differentiate between samples that are truly exhibiting mixed infection from those that harbour distinct virus populations due to sample mix-up. We have argued that this approach should be adopted routinely in virus sequence analyses to validate sample provenance.


2007 ◽  
Vol 59 (3) ◽  
pp. 37P-38P
Author(s):  
Gorana Stamenkovic ◽  
Milena Bozic ◽  
Snezana Jovanovic-Cupic ◽  
Ksenija Bojovic ◽  
Jasmina Simonovic

Author(s):  
Mohamed N.M.T. Al Khayat ◽  
Job F.H. Eijsink ◽  
Maarten J. Postma ◽  
Jan C. Wilschut ◽  
Marinus van Hulst

Objective: We aimed to assess the cost-effectiveness of hepatitis C virus (HCV) screening strategies among recently arrived migrants in the Netherlands. Methods: A Markov model was used to estimate the health effects and costs of HCV screening from the healthcare perspective. A cohort of 50,000 recently arrived migrants was used. In this cohort, three HCV screening strategies were evaluated: (i) no screening, (ii) screening of migrants from HCV-endemic countries and (iii) screening of all migrants. Results: Strategy (ii) screening of migrants from HCV-endemic countries compared to strategy (i) no screening, yielded an incremental cost-effectiveness ratio (ICER) of €971 per quality-adjusted life-years (QALYs) gained. Strategy (iii) screening of all migrants compared with strategy (ii) screening of migrants from HCV-endemic countries yielded an ICER of €1005 per QALY gained. The budget impact of strategy (ii) screening of migrants from HCV-endemic countries and strategy (iii) screening of all migrants was €13,752,039 and €20,786,683, respectively. Conclusion: HCV screening is cost-effective. However, the budget impact may have a strong influence on decision making.


Sign in / Sign up

Export Citation Format

Share Document